Cupid Limited CUPID NSE
Cupid Limited designs, manufactures, markets, and exports male and female condoms in India. The company offers water based lubricant jellies; in vitro diagnostic kits, including rapid diagnostic, viral transport medium, typhoid antibody, syphilis antibody, HIV 1 and 2 kit antibody, dengue IgG/IgM, malaria Pf-Pv and Pf-PAN antigen, hepatitis B (HbsAg) antigen, hepatitis C (HCV) antibody, pregnancy detection testing kit, LH ovulation testing kit, and dengue NS1 testing kit; and personal care products including deodorants, perfumes, toilet sanitizers, menstrual cups, petroleum jelly, hair and body oils, and hair removal sprays. It also exports its products to countries in Africa, Europe, Asia-Pacific, North America, Middle East, and South America. The company was formerly known as Cupid Condom Limited and changed its name to Cupid Limited in January 2006. The company was incorporated in 1993 and is based in Nashik, India.
READ MORE ›Market & Price
Valuation
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Growth (CAGR)
PROS
- Strong return on equity of 27.3%.
- Healthy ROCE of 30.9%.
- Excellent profit margin of 28.9%.
- Compounding revenue at 32.0% over 5 years.
- Profit CAGR of 50.8% over 5 years.
- Generates positive free cash flow.
CONS
- Trading at a high P/E of 163.4.
* The pros and cons are auto-generated from financial metrics.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth
No fundamental data available for this stock.
Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).
Peer comparison
Peer companies in the same sector (Consumer Defensive).
| # | Name | CMP ₹ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | CUPID Cupid Limited NSE | 129.06 | 163.37 | ₹17,354.19 Cr | - | 30.87% | 27.30% | 32.01% | 50.77% |
| 2 | HINDUNILVR Hindustan Unilever Limited NIFTY50NSE | 2,153.50 | 47.62 | ₹5.06 L Cr | 2.04% | 22.15% | 21.60% | 2.31% | 14.12% |
| 3 | ITC ITC Limited NIFTY50NSE | 286.90 | 17.39 | ₹3.59 L Cr | 5.58% | 36.47% | 29.34% | 3.65% | 2.54% |
| 4 | NESTLEIND Nestlé India Limited NIFTY50NSE | 1,421.50 | 78.10 | ₹2.74 L Cr | 0.84% | 59.30% | 76.34% | 17.01% | 23.05% |
| 5 | DMART Avenue Supermarts Limited NSE | 4,054.50 | 88.49 | ₹2.64 L Cr | - | 16.41% | 12.94% | 17.21% | 7.69% |
| 6 | VBL Varun Beverages Limited NSE | 528.00 | 56.17 | ₹1.79 L Cr | 0.38% | 19.44% | - | 17.26% | 26.57% |
| 7 | TATACONSUM Tata Consumer Products Limited NIFTY50NSE | 1,178.40 | 75.78 | ₹1.17 L Cr | 0.85% | 8.29% | 6.94% | 13.87% | 8.61% |
| 8 | MARICO Marico Limited NIFTY_MIDNSE | 821.70 | 60.60 | ₹1.06 L Cr | 0.49% | 39.00% | 41.39% | 12.00% | 10.61% |
| 9 | GODREJCP Godrej Consumer Products Limited NSE | 1,029.30 | 56.49 | ₹1.05 L Cr | 1.94% | 21.44% | 15.10% | 4.59% | 3.02% |
Quarterly Results
Figures in INR.
| Metric | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Revenue | - | 56.48 Cr | 59.80 Cr | 84.45 Cr | 93.50 Cr | 119.96 Cr |
| Cost of Revenue | - | 21.00 Cr | 24.09 Cr | 34.24 Cr | 35.14 Cr | 54.67 Cr |
| Gross Profit | - | 35.48 Cr | 35.71 Cr | 50.21 Cr | 58.35 Cr | 65.30 Cr |
| Operating Expenses | - | 23.34 Cr | 20.48 Cr | 23.10 Cr | 25.35 Cr | 29.05 Cr |
| Operating Income | - | 12.14 Cr | 15.23 Cr | 27.11 Cr | 33.00 Cr | 36.24 Cr |
| EBITDA | - | 18.03 Cr | 21.42 Cr | 34.20 Cr | 45.19 Cr | 49.60 Cr |
| Interest Expense | - | 77.74 L | 62.20 L | 70.15 L | 61.14 L | 87.24 L |
| Pretax Income | - | 16.00 Cr | 19.55 Cr | 32.19 Cr | 43.27 Cr | 47.45 Cr |
| Tax Provision | - | 4.49 Cr | 4.54 Cr | 8.06 Cr | 10.44 Cr | 11.19 Cr |
| Net Income | - | 11.51 Cr | 15.01 Cr | 24.13 Cr | 32.83 Cr | 36.26 Cr |
| Diluted EPS | - | 0.08 | 0.11 | 0.18 | 0.24 | 0.26 |
Profit & Loss (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | - | 155.51 Cr | 167.55 Cr | 183.52 Cr | 357.71 Cr |
| Cost of Revenue | - | 65.01 Cr | 59.29 Cr | 67.33 Cr | 148.14 Cr |
| Gross Profit | - | 90.50 Cr | 108.26 Cr | 116.20 Cr | 209.56 Cr |
| Operating Expenses | - | 52.12 Cr | 60.56 Cr | 78.95 Cr | 97.98 Cr |
| Operating Income | - | 38.37 Cr | 47.71 Cr | 37.25 Cr | 111.58 Cr |
| EBITDA | - | 45.57 Cr | 56.10 Cr | 61.39 Cr | 150.40 Cr |
| Interest Expense | - | 28.51 L | 59.76 L | 2.05 Cr | 2.81 Cr |
| Pretax Income | - | 42.32 Cr | 52.58 Cr | 54.86 Cr | 142.47 Cr |
| Tax Provision | - | 10.74 Cr | 12.73 Cr | 13.97 Cr | 34.23 Cr |
| Net Income | - | 31.58 Cr | 39.85 Cr | 40.89 Cr | 108.23 Cr |
| Diluted EPS | - | 0.23 | 0.30 | 0.29 | 0.79 |
Compounded Sales Growth
| 5 Years: | 32.01% |
| 1 Year: | 112.40% |
Compounded Profit Growth
| 5 Years: | 50.77% |
| 1 Year: | 214.20% |
Stock Price Performance
| 1 Year: | +494.91% |
| 6 Months: | +91.77% |
| 3 Months: | +54.79% |
| 1 Month: | +7.93% |
Balance Sheet (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Total Assets | - | 188.83 Cr | 319.94 Cr | 371.78 Cr | 553.22 Cr |
| Current Assets | - | 152.77 Cr | 249.69 Cr | 281.88 Cr | 385.39 Cr |
| Cash & Equivalents | - | 30.05 L | 11.90 Cr | 59.15 Cr | 168.67 Cr |
| Inventory | - | 19.10 Cr | 15.65 Cr | 41.67 Cr | 70.04 Cr |
| Receivables | - | 25.64 Cr | 47.98 Cr | 67.03 Cr | 100.79 Cr |
| Total Liabilities | - | 21.71 Cr | 18.65 Cr | 29.58 Cr | 102.42 Cr |
| Current Liabilities | - | 20.16 Cr | 17.01 Cr | 21.20 Cr | 82.60 Cr |
| Long Term Debt | - | - | - | - | 12.17 Cr |
| Total Debt | - | 5.97 Cr | 12.06 Cr | 18.99 Cr | 56.38 Cr |
| Total Equity | - | 167.12 Cr | 301.29 Cr | 342.19 Cr | 450.81 Cr |
| Shares Outstanding | - | 133.38 Cr | 134.18 Cr | 134.23 Cr | 134.47 Cr |
Cash Flows (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 32.71 Cr | 7.84 Cr | -11.14 Cr | 46.12 Cr |
| Investing Cash Flow | - | -21.86 Cr | -79.84 Cr | 44.68 Cr | 28.09 Cr |
| Financing Cash Flow | - | -10.95 Cr | 98.77 Cr | -1.46 Cr | 35.30 Cr |
| Capital Expenditure | - | -2.54 Cr | -25.00 Cr | -19.46 Cr | -24.69 Cr |
| Free Cash Flow | - | 30.17 Cr | -17.15 Cr | -30.59 Cr | 21.43 Cr |
| Net Change in Cash | - | -9.71 L | 26.77 Cr | 32.08 Cr | 109.52 Cr |
Ratios (Annual)
Figures in %.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Margin % | - | 58.2% | 64.6% | 63.3% | 58.6% |
| Operating Margin % | - | 24.7% | 28.5% | 20.3% | 31.2% |
| Net Margin % | - | 20.3% | 23.8% | 22.3% | 30.3% |
| ROE % | - | 18.9% | 13.2% | 11.9% | 24.0% |
| ROCE % | - | 22.7% | 15.7% | 10.6% | 23.7% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CUPID